News – Page 401 – Endpoints News

Crushed by PhIII antibiotic flop, PolyPid says it got FDA support for a comeback — by focusing on subgroup

3 years ago

Finch throws in the towel on microbiome journey, lets go of 77 employees

3 years ago

#JPM23: Fireside chat with Eisai's Ivan Cheung

3 years ago

Failed deal, bidding war paved the way for Ipsen's $952M rare disease buyout

3 years ago

Following positive data for pulmonary fibrosis drug, Pliant to sell $175M in stock

3 years ago

How the price of AstraZeneca's buyout of CinCor fell by $1.4B

3 years ago

WHO pushes for action by manufacturers and governments after warnings over contaminated cough syrups

3 years ago

Advocacy group accuses Novo Nordisk of violating FDA's 'fair balance' advertising rules

3 years ago

FDA lays the finishing touches on its plan to pull Makena

3 years ago

AbbVie cuts ribbon on cancer patient and family retreat space at St. Jude, funded by $50M pledge

3 years ago

#JPM23: Fireside chat with Barry Greene: 'There's no straight line to success'

3 years ago

After Lilly complaint, Novartis pulls claim in DTC cancer drug ad

3 years ago

TheracosBio aims to challenge Big Pharma blockbusters with newly-approved SGLT2 for diabetes

3 years ago

Pliant posts high-dose data of oral IPF drug with 'quite favorable' safety, outlines trial plans

3 years ago

On orphan drug exclusivity, FDA decides to go its own way after court loss

3 years ago

Over 130 employees let go from Merck KGaA R&D teams in Massachusetts

3 years ago

Iovance picks up IL-2 Proleukin for $200M+ upfront; Estrella Biopharma to wait for SPAC deal finish

3 years ago

FDA will consult outside advisors on whether Biogen’s ALS drug can be approved on a biomarker

3 years ago

VC investor Paul Manning donates $100M to UVA for new R&D institute

3 years ago

#JPM23: When will the IPO window open? What terms are startups getting? Here's what to expect from capital markets ...

3 years ago

FDA hopes to simplify and standardize Covid shots without making them interchangeable

3 years ago

Alvotech raises $137M months after FDA rejected Humira biosimilar

3 years ago

Updated: J&J axes four-year discovery alliance with Morphic

3 years ago

Updated: Takeda bets $400M cash on colorectal cancer drug in boost to China's Hutchmed

3 years ago

First page Previous page 398 399 400401402 403 404 Next page Last page